Saras Capital | Activity | F4

Team Portfolio Raise Champions Essays

F4/Saras Capital/Activity

Saras Capital Activity

Every public signal F4 has attached to this firm, with sources and cross-entity links.

Types

Time range

Investment

Participated in Biographica's £7M ($9.4M) seed round for AI-driven crop gene-editing target discovery.

Graphica

Graphica Saras Capital

esgtoday.comJAN 2026

JAN 2026

New Fund

Announced the final close of Saras Capital II LP, continuing the firm's tech-bio investment strategy with LPs including Isomer Capital.

Saras Capital II LP

haynesboone.comJAN 2026

JAN 2026

Investment

Participated in Cellbyte's $2.75M seed round for an AI-native pharma launch and market-access platform.

Cellbyte

CellbyteSaras Capital

finsmes.comNOV 2025

NOV 2025

Essay

Managing Partner Nadav Rosenberg published the firm's investment thesis on Founders, Europe, and AI in tech-bio.

Betting on Founders: How Saras Capital Is Backing the Future of Biotech

linkedin.comJUN 2025

JUN 2025

Investment

Participated in kyron.bio's €5.5M seed round for AI-driven antibody glycoengineering, led by HCVC.

Kyron.bio

Kyron.bio Saras Capital

european-biotechnology.comMAY 2025

MAY 2025